We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
- Authors
Blann AD; Khoo CW; Blann, Andrew D; Khoo, Chee W
- Abstract
As the risk factors for thrombosis are becoming better understood, so is the need for anticoagulation. The inherent difficulties with warfarin are such that a low-molecular-weight heparin (LMWH) is often the key therapeutic. However, there are several different species of LMWH available to the practitioner, which leads to the need for an objective guide. New agents are coming onto the marketplace, and these may supersede both warfarin and the heparins. The current report will review the biochemistry and pharmacology of different LWMHs and identify which are more suitable for the different presentations of venous thromboembolism. It will conclude with a brief synopsis of new agents which may supersede warfarin and heparin.
- Publication
Vascular Health & Risk Management, 2009, Vol 5, p693
- ISSN
1176-6344
- Publication type
journal article